Design and rational of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU)

Main Article Content

Gordon Sussman
Jacques Hebert
Wayne Gulliver
Charles Lynde
William H Yang
Olivier Chambenoit
Gretty Deutsch
Frederica DeTakacsy
Lenka Rihakova


urticaria, omalizumab, chronic urticaria, biologic therapy


Abstract Not Available

Most read articles by the same author(s)

1 2 > >>